News

TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Quir?nsalud Marbella and Hospital

Read more...

Getinge announces today an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use

Read more...

VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announced today a new strategic collaboration with Clarified

Read more...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies, has today announced the launch of Constellation

Read more...

GE HealthCare today announced US FDA 510(k) clearance of Precision DL ? a new, revolutionary deep learning-based image processing software included in GE HealthCare?s growing Effortless

Read more...

Takeda and HUTCHMED Limited today announced that the U.S. Food and Drug Administration has granted priority review of the New Drug Application (NDA) for fruquintinib, a highly selective

Read more...

FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic and financial advisory firm

Read more...

Synapse Medicine, the leader in medication success, and CompuGroup Medical, the leader in software for providers, have announced a partnership to accelerate innovation in prescribing

Read more...

IQVIA? a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, announced a groundbreaking partnership today

Read more...

Celltrion USA today announced that the U.S. Food and Drug Administration has approved Yuflyma, a high-concentration and citrate-free formulation of Humira? (adalimumab) biosimilar.

Read more...